23 related articles for article (PubMed ID: 6416891)
1. In situ imaging of metals in cells and tissues.
McRae R; Bagchi P; Sumalekshmy S; Fahrni CJ
Chem Rev; 2009 Oct; 109(10):4780-827. PubMed ID: 19772288
[No Abstract] [Full Text] [Related]
2. Autometallographic demonstration of gold in human fetal liver and placenta.
Møller-Madsen B; Danscher G; Uldbjerg N; Allen JG
Rheumatol Int; 1987; 7(1):47-8. PubMed ID: 3109003
[No Abstract] [Full Text] [Related]
3. Evidence that suramin and aurothiomalate are teratogenic in rat by disturbing yolk sac-mediated embryonic protein nutrition.
Freeman SJ; Lloyd JB
Chem Biol Interact; 1986 May; 58(2):149-60. PubMed ID: 3087638
[TBL] [Abstract][Full Text] [Related]
4. Localization of gold in the anterior pituitary gland of rats exposed to sodium aurothiomalate.
Møller-Madsen B; Thorlacius-Ussing O
Exp Mol Pathol; 1984 Aug; 41(1):74-80. PubMed ID: 6432575
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies on the distribution of gold, copper and zinc in the livers and kidneys of rats and hamsters after treatment with sodium [195Au]-aurothiomalate.
Mogilnicka EM; Webb M
J Appl Toxicol; 1981 Dec; 1(6):287-91. PubMed ID: 6821082
[TBL] [Abstract][Full Text] [Related]
6. Gold in the ovary of rats exposed to sodium aurothiomalate.
Møller-Madsen B; Simonsen OH; Doss DN; Danscher G
Exp Mol Pathol; 1985 Apr; 42(2):287-92. PubMed ID: 3920071
[TBL] [Abstract][Full Text] [Related]
7. A comparison of tissue gold levels in guinea-pigs after treatment with myocrisin injected intramuscularly and triethylphosphine gold chloride and myocrisin administered orally.
Kamel H; Brown DH; Ottaway JM; Smith WE; Cottney J; Lewis AJ
Agents Actions; 1978 Oct; 8(5):546-50. PubMed ID: 102133
[TBL] [Abstract][Full Text] [Related]
8. Transplacental transport of gold in rats exposed to sodium aurothiomalate.
Møller-Madsen B; Danscher G
Exp Mol Pathol; 1983 Dec; 39(3):327-31. PubMed ID: 6416891
[TBL] [Abstract][Full Text] [Related]
9. The biochemistry and subcellular distribution of gold in kidney tissue: implications for chrysotherapy and nephrotoxicity.
Shaw CF
Agents Actions Suppl; 1981; 8():509-28. PubMed ID: 6781238
[No Abstract] [Full Text] [Related]
10. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
Batlle Gualda E
Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
